HomeQuestion

Would you consider using a JAK inhibitor for CTCL?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

How do you manage cannabinoids (ex: medicinal, recreational) in dermatology?

4 Answers

Do you check IgA levels before starting IVIG for other autoimmune conditions?

63 Answers

Should ertapenem use in refractory HS be managed by ID, and how many times would you consider using it in a patient?

11 Answers

Would you give adjuvant radiation after complete resection of a small primary cutaneous follicular lymphoma of the scalp?

153 Answers

In an older patient with pembrolizumab-associated chronic eczematous dermatitis—worsened by dupilumab and with biopsies showing spongiotic dermatitis with atypical lymphocytes, would a trial of a JAK inhibitor be appropriate while monitoring for possible early CTCL?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service